home / stock / gnbt / gnbt news

GNBT News and Press, Generex Biotechnology From 10/10/19

Stock Information
Company Name: Generex Biotechnology
Stock Symbol: GNBT
Market: OTC
Website: generex.com
Menu
GNBT GNBT Quote GNBT Short GNBT News GNBT Articles GNBT Message Board
Get GNBT Alerts

News, Short Squeeze, Breakout and More Instantly...
GNBT - Generex Biotechnology Announces that Excellagen® Inventor, Dr. Lois Chandler will Present Clinical Data on Rapid Healing of Diabetic Foot Ulcers at The Symposium on Advanced Wound Care (SAWC) Fall Meeting

Special poster reception on October 13, 2019 , at Caesars Palace, Las Vegas, the official site of the SAWC Meeting Clinical data demonstrate accelerated healing of diabetic neuropathic foot ulcers with Excellagen wound conforming gel matrix MIRAMAR, Fla., Oct. 10, 2019 (GLOBE NEWSWIR...
GNBT - Generex Biotechnology Corporation Discusses Upcoming Revenue Increases and Growth with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - October 7, 2019) - The Stock Day Podcast welcomed Generex Biotechnology Corporation (OTCQB: GNBT) ("the Company"), an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personaliz...

GNBT - Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM

MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Tuesday October 15, 2019 at 9:30 am. Joseph Moscato, Generex President & Chief Executive Officer stated...

GNBT - Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) ( GNBT ) ( http://www.otcmarkets.com/stock/GNBT/quote ), is pleased to announce that their subsidiary, Olaregen Therapeutix, Inc. today officially launched the Excellagen 3.0 cc pre-filled...
GNBT - Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System

AvKare Medical, a Service-Disabled Veteran-Owned Small Business (SDVOSB), is a leading distributor of healthcare products Nationwide distribution and direct sales force to more than 170 VA medical centers and government healthcare facilities Excellagen wound conforming gel matr...

GNBT - Generex Biotechnology Announces Plans to Establish the NuGenerex Diabetes Research Center in Collaboration With Arizona Endocrinology Group & Paradise Valley Medical Family Medicine

Integrated, collaborative data systems enable population analytics Generex plans to accelerate the clinical development of Oral-Lyn-2 for Type-2 diabetes and Altsulin ®  for Type-1 diabetes MIRAMAR, Fla., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corpora...

GNBT - Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (KeytrudaÒ) for the Treatment of Triple Negative Breast Cancer

MIRAMAR, Fla., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that the NSABP Foundation, Inc. (NSABP) has enrolled the first patient in the study: A Phase II Clinical Trial...
GNBT - Generex Announces That the Process to Retire 20,375,900 GNBT "Pool Shares" is Complete

Retirement of Pool shares will be Reflected in 31.9% reduction in Outstanding Shares MIRAMAR, Fla., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the legal and regu...

GNBT - Generex Biotechnology Announces Webcast and Invites All Shareholders to See and Listen to the Corporate Presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference

President & CEO Joe Moscato and Head of Research Richard Purcell Present the “New” Generex to the Investment Community http://wsw.com/webcast/hcw5/gnbt/index.aspx   MIRAMAR, Fla., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (OTCQB:GNBT) ...

GNBT - Generex Bio signs letters of intent to establish NuGenerex Health MSO

Generex Biotechnology ( OTCQB:GNBT ) has signed letters of intent with Arizona Endocrinology Center and Paradise Valley Family Medicine to establish NuGenerex Health, LLC, a management services organization (MSO) focused on the delivery and management of healthcare services for patients wi...
Previous 10 Next 10